Re: Patel et al.: A cost-effectiveness analysis of pegcetacoplan for the treatment of geographic atrophy. (Ophthalmol Retina. 2024;8:25-31)

Other

Peer reviewed

Richard F. Spaide, Demetrios G. Vavvas, William E Smiddy and Nicolas A Yannuzzi

Ophthalmology Retina, Vol.8(7), pp.e24-23

2024-07-01

PMID: 38739069

Metrics

1 Record Views

Title: Re: Patel et al.: A cost-effectiveness analysis of pegcetacoplan for the treatment of geographic atrophy. (Ophthalmol Retina. 2024;8:25-31)
Creators: Richard F. Spaide - Vitreous Retina Macula Consultants of New York
Demetrios G. Vavvas - Massachusetts Eye and Ear Infirmary
William E Smiddy - UMMG Department of Ophthalmology
Nicolas A Yannuzzi - UMMG Department of Ophthalmology
Publication Details: Ophthalmology Retina, Vol.8(7), pp.e24-23
Grant note: Aristotle University of Thessaloniki (501100006470) Heidelberg Engineering, Genentech, Alcon, Janssen Board of Directors – University of Thessaloniki Topcon Europe Medical (501100010383) Genentech (100004328) International Retinal Imaging Society Roche (100004337) Alcon (100007816) Heidelberg Engineering (501100010313) Roche (http://data.elsevier.com/vocabulary/SciValFunders/100004337)
Academic Unit: UMMG Department of Ophthalmology; Miller School of Medicine
Language: English
Resource Type: Other
PMID: 38739069
Record Identifier: 991032860787502976